Onconetix (FRA:J4T) Total Tax Payable: €0.07 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:J4T Onconetix Inc FRA:J4T
21 GF Score
Price €11,985.00
! 4 Warning Signs
View Full Analysis

What is Onconetix Total Tax Payable?

Onconetix FRA:J4T 21 Total Tax Payable is €0.07 Mil as of Jun. 2026. GuruFocus rates FRA:J4T with a GF Score™ of 21/100. The stock has 4 warning signs investors should review.

Onconetix's Total Tax Payable for the quarter that ended in Jun. 2026 was €0.07 Mil.

Onconetix's quarterly Total Tax Payable increased from Dec. 2025 (€0.07 Mil) to Mar. 2026 (€0.07 Mil) but then stayed the same from Mar. 2026 (€0.07 Mil) to Jun. 2026 (€0.07 Mil).

Onconetix's annual Total Tax Payable declined from Dec. 2023 (€0.06 Mil) to Dec. 2024 (€0.04 Mil) but then increased from Dec. 2024 (€0.04 Mil) to Dec. 2025 (€0.07 Mil).

Onconetix Total Tax Payable Historical Data

* Premium members only.

The historical data trend for Onconetix's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Onconetix Total Tax Payable Chart

Onconetix Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Tax Payable
Get a 7-Day Free Trial 0.00 0.17 0.06 0.04 0.07

Onconetix Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Tax Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.07 0.07 0.07
FRA:J4T
21GF Score
Onconetix Inc FRA:J4T
Total Tax Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Onconetix Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Frequently Asked Questions Learn more about Total Tax Payable →
What does a Total Tax Payable of €0.07 Mil mean?
Onconetix (FRA:J4T) has a Total Tax Payable of €0.07 Mil as of Jun. 2026. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on Onconetix and its competitors.
Is Onconetix's Total Tax Payable too high?
Onconetix's current Total Tax Payable is €0.07 Mil. Overall, Onconetix has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Onconetix's Total Tax Payable compare to SPRC and ACUT?
Onconetix's Total Tax Payable of €0.07 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Tax Payable for a Biotechnology company?
A good Total Tax Payable depends on the Biotechnology industry context. However, Total Tax Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Tax Payable mean?
A high Total Tax Payable can signal that a stock is expensive relative to its fundamentals. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on Onconetix and its competitors. Onconetix's current Total Tax Payable is €0.07 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onconetix stock overvalued right now?
Onconetix (FRA:J4T) has a current Total Tax Payable of €0.07 Mil. The current Total Tax Payable is €0.07 Mil. Onconetix's overall GF Score™ is 21/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Tax Payable calculated?
Total Tax Payable is calculated from a company's financial statements. For Onconetix (FRA:J4T), the current Total Tax Payable is €0.07 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Onconetix Business Description

Other Exchanges ONCO:USA
Address 201 E. Fifth Street, Suite 1900, Cincinnati, OH, USA, 45202
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The company owns Proclarix, an in vitro diagnostic test for prostate cancer, approved for sale in the European Union. Additionally, it is focused on marketing Proclarix in the U.S. as a lab-developed product. Onconetix operates in one segment: commercial. Geographically, the company generates maximum revenue from Switzerland and the rest from the United Kingdom.
21GF Score

Get the complete analysis for FRA:J4T

Total Tax Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11,985.00
Price